# INCELL Corporation LLC – FDA Inspection, Sep 29, 2023

Source: https://www.keypedia.com/records/fda_inspections/incell-corporation-llc/ca293cf5-513f-4d39-a80c-fb04f3808393
Source feed: FDA_Inspections

> FDA inspection 1219086 of INCELL Corporation LLC, September 29, 2023. Classification: Official Action Indicated (OAI). 8 citations under 21 CFR part 211. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1219086
- Company Name: INCELL Corporation LLC
- Inspection Date: 2023-09-29
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 8
- Enforcement Type: WARNING_LETTER

## Related Documents

- FDA Inspection 1097865 - 2019-07-18
- FDA Inspection 1069229 - 2018-09-27
- [FDA Inspection 942800 - 2015-09-01](https://www.keypedia.com/records/fda_inspections/incell-corporation-llc/29cc629f-842b-4445-b2da-7dc0842754ba)
- FDA Inspection 860185 - 2013-12-19

## Related Officers

- [Bobbi J. Miller](https://www.keypedia.com/people/bobbi-j-miller/e005d16b-d354-4447-8e58-d540b0710467)
- [Company Rep](https://www.keypedia.com/people/richard-t-riggie/d07a4551-08b4-44f7-b7d2-02ae3c5dc1e2)

Company: https://www.keypedia.com/companies/incell-corporation-llc/d4d60997-99ce-45b7-be66-c76ff6e80ec5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
